e-learning
resources
Virtual 2020
Pre-Congress Content
Asthma and COPD: How genetic and environment influences its developement?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested
A. Zaharie (Bucharest, Romania), V. Cosei (Bucure?ti, Romania), A. Croitoru (Bucure?ti, Romania), L. Davidescu (Oradea, Romania), J. Chorostowska-Wynimko (Warsaw, Poland), R. Ulmeanu (Bucure?ti, Romania)
Source:
Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Session:
Asthma and COPD: How genetic and environment influences its developement?
Session type:
E-poster session
Number:
1130
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Zaharie (Bucharest, Romania), V. Cosei (Bucure?ti, Romania), A. Croitoru (Bucure?ti, Romania), L. Davidescu (Oradea, Romania), J. Chorostowska-Wynimko (Warsaw, Poland), R. Ulmeanu (Bucure?ti, Romania). Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested. 1130
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil
Source: Eur Respir J 2003; 22: Suppl. 45, 499s
Year: 2003
Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Year: 2021
Implementation of screening program for alpha-1 antitrypsin deficiency in Spain
Source: Annual Congress 2004 - Emphysema and oxygen therapy
Year: 2004
Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Alpha-1 antitrypsin deficiency and lung cancer: Description of a cohort of patients in northwestern Spain
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes
Source: Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020
Year: 2020
Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Late Breaking Abstract - Genetic diagnosis of alpha-1 antitrypsin deficiency using saliva samples
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020
The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Alpha-1 antitrypsin deficiency – a potentially fatal disease
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017
Rare alpha-1 antitrypsin mutations in the Irish population
Source: Annual Congress 2012 - COPD inflammation and genes
Year: 2012
Rare alpha-1 antitrypsin mutations in the Irish population
Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases
Year: 2011
The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011
Alpha-1 antitrypsin deficiency severity and the risk of COVID-19
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Year: 2021
Estimates of the prevalence of alpha-1 antitrypsin deficiency PI*S and PI*Z alleles and the numbers at risk in Europe
Source: Eur Respir J 2005; 26: Suppl. 49, 219s
Year: 2005
Anxiety in a population tested for alpha-1 antitrypsin deficiency.
Source: International Congress 2019 – Genes and environment
Year: 2019
Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in!
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept